3D PATHOLOGY / Illumos
3D PATHOLOGY / Illumos
A NEW DIMENSION IN CANCER ASSESSMENT
A NEW DIMENSION IN CANCER ASSESSMENT
5-Minute Cancer Diagnosis
by 3D Pathology
5-Minute Cancer Diagnosis
by 3D Pathology
Biopsy to image in five minutes. The whole specimen. At the point of care.
Biopsy to image in five minutes. The whole specimen. At the point of care.
WHY 3D PATHOLOGY?
WHY 3D PATHOLOGY?
Because cancers can hide in a single plane.
But doctors are looking at ONE random plane now.
Because cancers can hide in a single plane.
But doctors are looking at ONE random plane now.
Because cancers can hide in a single plane.
But doctors are looking at ONE random plane now.
Less than
Less than
Less than
1%
1%
1%
Tissue examined
Tissue examined
Tissue examined
Of tissue volume in conventional pathology, as a limitation of physical sectioning of tissue.
Of tissue volume in conventional pathology, as a limitation of physical sectioning of tissue.
Of tissue volume in conventional pathology, as a limitation of physical sectioning of tissue.
Up to
Up to
Up to
25%
25%
25%
Cancer missed in the same tissue
Cancer missed in the same tissue
Cancer missed in the same tissue
Of lung cancer patients with an initially negative lung biopsy had cancer missed in that same biopsy tissue.
Of lung cancer patients with an initially negative lung biopsy had cancer missed in that same biopsy tissue.
Of lung cancer patients with an initially negative lung biopsy had cancer missed in that same biopsy tissue.
Up to
Up to
Up to
30%
30%
30%
Repeat lung biopsy needed
Repeat lung biopsy needed
Repeat lung biopsy needed
Due to non-diagnostic results, such as insufficient quantity, atypical cells and so on.
Due to non-diagnostic results, such as insufficient quantity, atypical cells and so on.
Due to non-diagnostic results, such as insufficient quantity, atypical cells and so on.
Sampling impacts accuracy. Accuracy determines outcomes.
Sampling impacts accuracy. Accuracy determines outcomes.
THE WORKFLOW
THE WORKFLOW
Three steps. A new perspective.
Three steps. A new perspective.
01
01

Fresh intact biopsy tissue is fixed, stained and cleared in patented solutions
Fresh intact biopsy tissue is fixed, stained and cleared in patented solutions
02
02

The entire tissue is imaged using a portable laser microscope
The entire tissue is imaged using a portable laser microscope
03
03

Pathologists remotely review the image stack in real time and provide feedback
Pathologists remotely review the image stack in real time and provide feedback
TISSUE TO IMAGE
TISSUE TO IMAGE
≈5 minutes
≈5 minutes
What makes 3D pathology different?
What makes 3D pathology different?
FFPE (conventional pathology)
FFPE (conventional pathology)
Frozen section
Frozen section
3D pathology “Speedrun”
3D pathology “Speedrun”
Tissue volume examined
Tissue volume examined
<1%
<1%
<1%
<1%
100%
100%
Sectioning method
Sectioning method
Physical (microtome)
Physical (microtome)
Physical (cryostat)
Physical (cryostat)
Optical (laser scanning microscopy)
Optical (laser scanning microscopy)
Tissue condition after testing
Tissue condition after testing
Partially consumed by sectioning
Partially consumed by sectioning
Partially consumed; freezing artifacts may persist
Partially consumed; freezing artifacts may persist
Fully intact
Fully intact
Same examined tissue usable for downstream tests (e.g. IHC, NGS)
Same examined tissue usable for downstream tests (e.g. IHC, NGS)
No, tissue is depleted with each section
No, tissue is depleted with each section
No, tissue is depleted with each section
No, tissue is depleted with each section
Yes; the same tissue is compatible with validated downstream analyses
Yes; the same tissue is compatible with validated downstream analyses
Image quality
Image quality
Good (gold standard)
Good (gold standard)
Lower; with ice-crystal artifacts
Lower; with ice-crystal artifacts
Comparable to FFPE
Comparable to FFPE
Turnaround time
Turnaround time
Days to weeks
Days to weeks
~20–45 minutes
~20–45 minutes
~5 minutes
~5 minutes
Location
Location
Pathology lab
Pathology lab
Pathology lab
Pathology lab
Point of care, with remote pathologist access
Point of care, with remote pathologist access
CLINICAL STUDIES IN PROGRESS
CLINICAL STUDIES IN PROGRESS
Across tissue types. Toward clinical evidence.
Across tissue types. Toward clinical evidence.
Multiple clinical studies are in progress across different tissue types and clinical applications.
Multiple clinical studies are in progress across different tissue types and clinical applications.

Lung biopsy
Lung biopsy
Lung biopsy

Colonic polyp
Colonic polyp
Colonic polyp

Prostate biopsy
Prostate biopsy
Prostate biopsy

Bladder cancer
Bladder cancer
Bladder cancer

Brain tumor
Brain tumor
Brain tumor

Skin cancer
Skin cancer
Skin cancer
A better future
A better future
How 3D pathology is changing the patient journey.
How 3D pathology is changing the patient journey.
01
01
ASSESSMENT
ASSESSMENT
Improved diagnostic accuracy
Improved diagnostic accuracy
02
02
DIAGNOSIS
DIAGNOSIS
Early diagnosis and intervention
Early diagnosis and intervention
03
03
DURING SURGERY
DURING SURGERY
Timely feedback on sample adequacy and margin status
Timely feedback on sample adequacy and margin status
04
04
OPERATIVE CARE
OPERATIVE CARE
Reduced operating time
Reduced operating time
05
05
FOLLOW-UP
FOLLOW-UP
Reduced repeat biopsy and reoperation rates
Reduced repeat biopsy and reoperation rates
06
06
LONG-TERM IMPACT
LONG-TERM IMPACT
AI pathology and biomarker discovery
AI pathology and biomarker discovery
Rich 3D tissue data could support AI model development and the discovery of new spatial biomarkers.
Rich 3D tissue data could support AI model development and the discovery of new spatial biomarkers.
Bring your clinical question.
Bring your clinical question.
Tell us how 3D pathology can help your patients. Together we can make it come true.
Tell us how 3D pathology can help your patients. Together we can make it come true.
3D PATHOLOGY · For professional collaboration inquiries · Hong Kong, US
For professional collaboration inquiries.
Hong Kong, US